The Finnish trial of prostate cancer screening: where are we now?
Open Access
- 1 December 2003
- journal article
- clinical trial
- Published by Wiley in BJU International
- Vol. 92 (s2), 22-26
- https://doi.org/10.1111/j.1465-5101.2003.04397.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Guidelines for processing and reporting of prostatic needle biopsiesJournal of Clinical Pathology, 2003
- Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled studyUrology, 2002
- Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trialInternational Journal of Cancer, 2001
- PROSTATE CANCER SCREENING WITHIN A PROSTATE SPECIFIC ANTIGEN RANGE OF 3 TO 3.9 NG./ML.:Journal of Urology, 2001
- SAFETY AND MORBIDITY OF FIRST AND REPEAT TRANSRECTAL ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSIES:Journal of Urology, 2001
- USE OF THE COMPLEX BETWEEN PROSTATE SPECIFIC ANTIGEN AND ??1-PROTEASE INHIBITOR FOR SCREENING PROSTATE CANCERJournal of Urology, 2000
- Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and FinlandThe New England Journal of Medicine, 2000
- The UCLA Prostate Cancer IndexMedical Care, 1998
- Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerThe Lancet, 1994
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992